C.M. Carver, D.S. Reddy: Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. In: Psychopharmacology. Band230, Nr.2, 2013, S.151–188, doi:10.1007/s00213-013-3276-5.
D.S. Reddy: The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. In: Epilepsy Research. Band85, Nr.1, 2009, S.1–30, doi:10.1016/j.eplepsyres.2009.02.017.
A. Tvrdeić, L. Poljak: Neurosteroids, GABAA receptors and neurosteroid based drugs: are we witnessing the dawn of the new psychiatric drugs? In: Endocrine Oncology and Metabolism. Band2, Nr.2, 2016, S.49–60, doi:10.21040/eom/2016.2.7.
S.G. Brickley, I. Mody: Extrasynaptic GABAAreceptors: Their function in the CNS and implications for disease. In: Neuron. Band73, Nr.1, 2012, S.23–34, doi:10.1016/j.neuron.2011.12.012.
P.D. Negraes et al.: Altered network and rescue of human neurons derived from individuals with early-onset genetic epilepsy. In: Nature. Molecular Psychiatry. Band26, 2021, S.7047–7068, doi:10.1038/s41380-021-01104-2.
B. Terzic, M. Felicia Davatolhagh, Y. Ho, S. Tang, Yu-Ting Liu, Z. Xia, Y. Cui, M. V. Fuccillo, Z. Zhou: Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder–related deficits. In: Journal of Clinical Investigation. Band131, Nr.20, 2021, S.e143655, doi:10.1172/JCI143655.
M. J. Maguire, S. J .Nevitt, et al.: Treatments for seizures in catamenial (menstrual‐related) epilepsy. In: Cochrane Database of Systematic Reviews. Band10, Nr.10, 2019, doi:10.1002/14651858.CD013225.pub2.
